Segmentation of Intravenous Solutions

23-Mar-2012 | News-Press Release

This market insight report on IV (Intravenous) Solutions is analyzed by Type and Nutrients for each of the geographic regions-North America, Europe, Asia-Pacific and Rest of World. The global IV Solutions market segments includes by Type- Partial Parenteral Nutrition (PPN) & Total Parenteral Nutrition (TPN); by Nutrients-Carbohydrates, Salt and Electrolytes, Minerals and Vitamins and Amino Acids. Estimations and predictions for the total global IV solutions market are given by geographic regions. Business profiles of 17 major companies are discussed in the report.
 The report covers more than 50 companies that are engaged in IV Solutions and related products. Major Contract Research Organizations serving IV Solution market are also covered in the Corporate Directory section of this report. Information related to product developments, partnerships, collaborations, and mergers and acquisitions is also included in the report. A total of 192 exclusive graphically represented exhibits complement the text. Market Research Companies
 Report Highlights

 This report may help strategists, investors, laboratories, contract research organizations, biotechnology & Healthcare companies, academic professionals, drug approval authorities, and other organizations to –
* Identify Market Opportunities
 * Review and Analyze Global and Regional Markets
 * Gauge Market Potential for your Products
 * Identify Competition
 * Use Market Research for exploring new areas
 Acquire Meaningful Guidelines for Strategic Planning
* Gear up for Market Entry
 * Get Actionable Information
 * Analytics and data presented in each report pertain to several parameters such as –
 * Global and Regional Market Sizes, Market Shares, Market Trends
 * Product (Global and Regional) Market Sizes, Market Shares, Market Trends
 * Technology Trends
 * Corporate Intelligence
 * Key Companies By Sales, Brands, Products
 * Other Strategic Business Affecting Data
 Key Report Findings
Global Intravenous Solutions market is projected to grow at 13.79% compounded annually from 2005 through 2015. Several companies that supply intravenous solutions have come up with innovations in their product lines. An industry leader in this field, Baxter International, rapidly expanded its product line of pre-mixed frozen intravenous solutions. Abbot Labs designed a system in which bottles of powdered drugs could be directly introduced into the bag of intravenous fluid as required. The lids of these bottles are screwed open inside the sterile bags and the drugs are subsequently introduced into the solution and mixed by shaking.
 Intravenous feeding is the short-term administration of supplementary nutrients through a solution that is introduced into the vein. Peripheral intravenous feeding refers to infusion of the fluid in a small vein on the surface of an arm, leg or the scalp. On the other hand, central venous feeding refers to infusion into a large vein which is embedded deep within a body. Only limited quantities of nutrients can be administered through peripheral intravenous feeding as there is the danger of incurring phlebitis and/or clots (thrombi) if concentrated solutions are used. However, in central venous feeding it is possible to infuse concentration nutrient solutions as the rapid blood flow in the central veins can promptly dilute the solution thereby minimizing the possibility of causing irritation to the vein.
 When IV solutions are produced locally in medically emerging countries, the resulting return on initial investments can be quite small. It is estimated that profitability would stand at only 50% of the total production capacity. The production costs that are incurred in developing IV solutions are 45% to 65% lower than the existing market price for primary product lines. These estimates are based on U.S. cost figures. When the U.S. system of calculation is used, both direct and indirect labor costs are the largest cost factors. However, in developing nations, the labor cost is relatively low and the cost of IV solutions is much higher. Therefore, the actual production cost can be estimated to be 60% to 90% lower than the market price of the product. There is a very high demand for IV solutions. Therefore, even if a situation arises in which production is more than the local demand, there are still excellent prospects of making national sales as well as sales through exports. The raw materials that are required to produce IV solutions are easy to procure as they are readily available in local markets.
 For more information kindly visit :
Segmentation of Intravenous Solutions
 Bharat Book Bureau
 Tel: +91 22 27810772 / 27810773
 Fax: + 91 22 27812290
 Follow us on twitter:!/Sandhya3B

Show HTML Embed Snippet

This release was submitted by a PRSafe user.
Any communication related to the content of this release should be sent to the release submitter.

Contact Info

From Name
From Email
From Company
Login to Submit Email

Author Info

Tag Cloud


More Releases


Add a Comment